Pfizer Ltd is primarily involved in marketing, exporting, manufacturing, and trading of pharmaceutical products. It produces goods through its in-house facility and
Pfizer Limited Q3FY23 Earnings Story
Categories
Pharmaceutical
Panacea Biotec Q3FY23; 26% Fall in Revenue
Panacea Biotec Limited’s revenue in Q3FY23 fell 26% to ₹ 11,520 lakhs. Consolidated Profit After Tax came at ₹ 1,937 lakhs in
Lupin Ltd (LUPIN) Q3 FY23 Earnings Concall Transcript
Lupin Ltd (NSE:LUPIN) Q3 FY23 Earnings Concall dated Feb. 10, 2023. Corporate Participants: Vinita Gupta -- Chief Executive Officer Ramesh Swaminathan -- Executive Director, Global Chief
Lupin Limited Q3FY23; 47% Growth in Profits
Lupin Limited’s revenue in Q3FY23 rose 13% to ₹ 1,97,66,301 lakhs. Consolidated Profit After Tax came at ₹ 8,34,871 lakhs in Q3FY23
Sun Pharmaceutical Q3FY23; 3% Growth in Profits
Sun Pharmaceutical Industries Limited’s revenue in Q3FY23 rose 14% to ₹ 112,410 millions. Consolidated Profit After Tax came at ₹ 21,808 millions
Aurobindo Pharma Q2FY23; 41% Fall in Profits
Aurobindo Pharma Ltd.‘s revenue in Q2FY23 fell 3% to ₹ 5,739 crores. Consolidated Profit came at ₹ 409 crores showcasing a 41%
Divi’s Laboratories Q2FY23; 19% Fall in Profits
Divi's Laboratories Ltd.'s revenues in Q2FY23 fell 7% to ₹ 1,855 crores. Consolidated Profit came at ₹ 494 crores showcasing a 19%
Torrent Pharmaceuticals Limited Q2FY23; Profits down by 1%
Torrent Pharmaceuticals Ltd.‘s Revenues for Q2 FY23 has increased by 7% YoY to ₹ 2,291 crores. Net Profit fell by 1% YoY
Apollo Hospitals Enterprise Limited Q1FY23; 35% fall in Profits
Revenue for Q1 FY23 has increased by 1% YoY to ₹ 37,956 millions. Profits have fallen by 35% YoY to ₹ 31,711
Aurobindo Pharma Limited Q1FY23; 32% fall in Profits
Revenue for Q1 FY23 has increased by 9% YoY to ₹ 6,235.9 crores. Profits have fallen by 32% YoY to ₹ 520.5
Zydus Lifesciences Ltd Q1FY23; Profit suffer with rise in expenses
Revenue for Q1 FY23 has increased by 1.8% YoY to ₹40,727 millions. Profits decreased by 12% YoY to ₹5,183 millions because Total
Piramal Enterprises Limited Q1FY23; 8% fall in Profits
Revenue for Q1 FY23 has increased by 22% YoY to ₹ 3,548 crores. Profits have fallen by 8% YoY to ₹ 496.09
Dr Reddy’s Laboratories Ltd. Q1FY23; 6% growth in Revenue
Revenue for Q1 FY23 has increased by 6% YoY to ₹ 52,154 millions. Profits have grown by 108% YoY to ₹ 11,876